Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. 2012

Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
Aix-Marseille University, CRN2M, UMR 7286-CNRS, 51, Bd Pierre Dramard, 13344 Marseille, France. t.cuny@chu-nancy.fr

OBJECTIVE As prolactinomas fail to respond to dopamine agonist (DA) in 10-20% of cases, we hypothesized that somatostatin subtype 2 receptor (sst2) overexpression in DA-resistant prolactinomas may enhance suppression of prolactine (PRL) using chimeric agonist (dopastatin) that simultaneously binds sst2 and the dopamine subtype 2 receptor (D2DR). METHODS PRL suppression by octreotide, sst5 agonist, sst2-D2DR agonist (BIM-23A760 dopastatin) and cabergoline was assessed in primary cultures of seven DA-resistant prolactinomas overexpressing sst2. RESULTS sst2 was effectively overexpressed via adenoviral expression in prolactinomas (38.1±7.4 vs. 0.1±0.1 copy/copy β-Gus) and induced octreotide sst2-mediated PRL suppression that remained lower than that induced by DA. BIM-23A760 inhibited PRL similarly to cabergoline both in the control and sst2-expressing cells. Antagonist experiments confirmed predominant dopaminergic effect in dopastatin activity. CONCLUSIONS sst2 was successfully overexpressed in prolactinomas. However BIM-23A760 was unable to enhance PRL suppression underlining a predominant dopaminergic contribution in its action.

UI MeSH Term Description Entries
D008297 Male Males
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077465 Cabergoline An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE. 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea,1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate,Cabaser,Cabaseril,Cabergoline Diphosphate,Dostinex,FCE 21336,FCE-21336,Galastop
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses

Related Publications

Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
January 1984, Acta endocrinologica,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
October 2012, Molecular and cellular endocrinology,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
August 1986, Clinical endocrinology,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
January 1989, Hormone research,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
April 1996, Cancer research,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
October 2005, Human gene therapy,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
January 2022, Frontiers in endocrinology,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
April 1999, Human gene therapy,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
February 2005, British journal of pharmacology,
Thomas Cuny, and Amira Mohamed, and Thomas Graillon, and Catherine Roche, and Céline Defilles, and Anne-Laure Germanetti, and Bettina Couderc, and Dominique Figarella-Branger, and Alain Enjalbert, and Anne Barlier, and Alexandru Saveanu
March 1985, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!